April 2024
1. KMIETOWICZ Z
   MMR uptake in England quadruples in 2024.
   BMJ. 2024;385:q972.
   

   >> Share

   
   
2. DE OLIVEIRA ANDRADE R
   After years of decline, Brazil sees vaccination coverage rise in 2023.
   BMJ. 2024;385:q668.
   

   >> Share

   
   March 2024
3. MAHASE E
   Measles: South Sudan reports 12 000 cases in three months.
   BMJ. 2024;384:q777.
   

   >> Share

   
   
4. MAHASE E
   Covid-19: Pfizer vaccine to be available privately at pharmacy chain Boots from April.
   BMJ. 2024;384:q762.
   

   >> Share

   
   
5. WISE J
   RSV: Paediatricians call on government to expedite infant vaccination programme.
   BMJ. 2024;384:q706.
   

   >> Share

   
   
6. LEEDOM M
   How climate change is changing vaccination planning.
   BMJ. 2024;384:q360.
   

   >> Share

   
   
7. FISHER M
   Understanding the history of vaccine hesitancy and current mistrust in healthcare.
   BMJ. 2024;384:q539.
   

   >> Share

   
   
8. MAJEED A
   Increasing measles, mumps, and rubella (MMR) vaccine uptake in primary care.
   BMJ. 2024;384:q552.
   

   >> Share

   
   February 2024
9. WISE J
   Covid-19 taskforce called for a new national vaccine agency to prepare for future pandemics.
   BMJ. 2024;384:q534.
   

   >> Share

   
   
10. TAYLOR L
    Dengue fever: Brazil rushes out vaccine as climate change fuels unprecedented surge.
    BMJ. 2024;384:q483.
    

    >> Share

    
    
11. WISE J
    Covid-19: Two rare vaccine side effects detected in large global study.
    BMJ. 2024;384:q488.
    

    >> Share

    
    
12. NOLAN T
    RSV vaccination roll-outs and electronic nicotine delivery systems.
    BMJ. 2024;384:q427.
    

    >> Share

    
    
13. WORSHAM CM, Bray CF, Jena AB
    Optimal timing of influenza vaccination in young children: population based cohort study.
    BMJ. 2024;384:e077076.
    

    >> Share

    
    
14. 
    Covid-19 vaccine effectiveness against post-covid-19 condition among 589 722 individuals in Sweden: population based cohort study.
    BMJ. 2024;384:q434.
    

    >> Share

    
    
15. WISE J
    GMC admits error in decision over whether to investigate doctor's claims over covid vaccine.
    BMJ. 2024;384:q433.
    

    >> Share

    
    
16. HEALY A
    Measles: increasing vaccine uptake is vital in preventing outbreaks.
    BMJ. 2024;384:q402.
    

    >> Share

    
    
17. MAHASE E
    Measles: 500 cases are confirmed in England as clusters appear around the country.
    BMJ. 2024;384:q417.
    

    >> Share

    
    
18. LOPEZ-BELTRAN A, Cookson MS, Guercio BJ, Cheng L, et al
    Advances in diagnosis and treatment of bladder cancer.
    BMJ. 2024;384:e076743.
    

    >> Share

    
    
19. BEDFORD H, Elliman D
    Measles rates are rising again.
    BMJ. 2024;384:q259.
    

    >> Share

    
    January 2024
20. BOYTCHEV H
    RSV vaccines administered in error to infants and pregnant people, CDC reports.
    BMJ. 2024;384:q236.
    

    >> Share

    
    
21. WILKINSON E
    Measles outbreaks: Investing in patient relationships through GP continuity will be key to boosting MMR confidence.
    BMJ. 2024;384:q221.
    

    >> Share

    
    
22. WISE J
    Measles: Birmingham outbreak declared a national incident and likely to spread.
    BMJ. 2024;384:q159.
    

    >> Share

    
    
23. IACOBUCCI G
    Covid-19: Vaccines have saved at least 1.4 million lives in Europe, WHO reports.
    BMJ. 2024;384:q125.
    

    >> Share

    
    
24. LARSON HJ, Lin L
    Generative artificial intelligence can have a role in combating vaccine hesitancy.
    BMJ. 2024;384:q69.
    

    >> Share

    
    
25. RUGGERI K, Vanderslott S, Yamada Y, Argyris YA, et al
    Behavioural interventions to reduce vaccine hesitancy driven by misinformation on social media.
    BMJ. 2024;384:e076542.
    

    >> Share

    
    
26. ASTUTI SI, Sufehmi H, Wilhelm E
    Centring health workers and communities is key to building vaccine confidence online.
    BMJ. 2024;384:q82.
    

    >> Share

    
    
27. IACOBUCCI G
    Measles: Warning given over low MMR uptake after cases rise to 200 in West Midlands.
    BMJ. 2024;384:q113.
    

    >> Share

    
    
28. COOPER S, Gadanya MA, Kaawa-Mafigiri D, Katoto PDMC, et al
    Using social media to build confidence in vaccines: lessons from community engagement and social science research in Africa.
    BMJ. 2024;384:e075564.
    

    >> Share

    
    
29. JAY R
    NHS eligibility criteria for shingles vaccination is ageist.
    BMJ. 2024;384:p2991.
    

    >> Share

    
    December 2023
30. MAHASE E
    Vaccine appointments and records will be available through NHS app, says NHS England.
    BMJ. 2023;383:p2945.
    

    >> Share

    
    
31. ARSHAD Z, Nazareth J, Pareek M
    Learning to live with covid-19: testing, vaccination, and mask wearing still play a key part in managing the pandemic.
    BMJ. 2023;383:p2943.
    

    >> Share

    
    
32. 
    Human papillomavirus vaccination and cervical cancer risk.
    BMJ. 2023;383:p2901.
    

    >> Share

    
    November 2023
33. DYER O
    Pfizer sues Poland over unclaimed covid vaccines.
    BMJ. 2023;383:2810.
    

    >> Share

    
    
34. LUNDBERG-MORRIS L, Leach S, Xu Y, Martikainen J, et al
    Covid-19 vaccine effectiveness against post-covid-19 condition among 589 722 individuals in Sweden: population based cohort study.
    BMJ. 2023;383:e076990.
    

    >> Share

    
    
35. SIVAN M, Ormerod M, Maini R
    Does timely vaccination help prevent post-viral conditions?
    BMJ. 2023;383:p2633.
    

    >> Share

    
    
36. KMIETOWICZ Z
    Measles: Royal college issues updated guidance as outbreaks loom.
    BMJ. 2023;383:p2736.
    

    >> Share

    
    
37. TANNE JH
    Measles cases and deaths are increasing worldwide, say WHO and CDC.
    BMJ. 2023;383:2733.
    

    >> Share

    
    
38. MAHASE E
    Routinely offer MenB jabs to prevent gonorrhoea, UK vaccine committee recommends.
    BMJ. 2023;383:p2696.
    

    >> Share

    
    
39. BOYTCHEV H
    Concerns over informed consent for pregnant women in Pfizer's RSV vaccine trial.
    BMJ. 2023;383:p2620.
    

    >> Share

    
    
40. KMIETOWICZ Z
    Offer children chickenpox vaccine with MMR, JCVI recommends.
    BMJ. 2023;383:p2677.
    

    >> Share

    
    
41. BLOCK J
    Is the US's Vaccine Adverse Event Reporting System broken?
    BMJ. 2023;383:p2582.
    

    >> Share

    
    
42. MBINTA JF, Simpson CR
    Long term effectiveness of live herpes zoster vaccine.
    BMJ. 2023;383:p2497.
    

    >> Share

    
    
43. KLEIN NP, Bartlett J, Fireman B, Marks MA, et al
    Effectiveness of the live zoster vaccine during the 10 years following vaccination: real world cohort study using electronic health records.
    BMJ. 2023;383:e076321.
    

    >> Share

    
    October 2023
44. BEDFORD H, Skirrow H
    Action to maximise childhood vaccination is urgently needed.
    BMJ. 2023;383:p2426.
    

    >> Share

    
    
45. LIMB M
    Covid-19: Confusion around vaccination during pregnancy likely to have contributed to deaths of 27 women in the UK.
    BMJ. 2023;383:p2388.
    

    >> Share

    
    
46. DYER C
    Surgeon who repeated false claims about covid and vaccines while suspended is struck off.
    BMJ. 2023;383:p2308.
    

    >> Share

    
    
47. MAHASE E
    WHO recommends second vaccine for malaria prevention in children.
    BMJ. 2023;383:p2291.
    

    >> Share

    
    
48. TANNE JH
    Covid-19: Vaccine hesitancy and access affect uptake of new boosters.
    BMJ. 2023;383:2271.
    

    >> Share

    
    September 2023
49. 
    Efficacy and safety of an inactivated virus-particle vaccine for SARS-CoV-2, BIV1-CovIran: randomised, placebo controlled, double blind, multicentre, phase 3 clinical trial.
    BMJ. 2023;382:p2193.
    

    >> Share

    
    
50. KMIETOWICZ Z
    BMA calls for investigation into debacle over covid and flu vaccinations.
    BMJ. 2023;382:p2184.
    

    >> Share

    
    
51. MOHRAZ M, Vahdat K, Ghamari SH, Abbasi-Kangevari M, et al
    Efficacy and safety of an inactivated virus-particle vaccine for SARS-CoV-2, BIV1-CovIran: randomised, placebo controlled, double blind, multicentre, phase 3 clinical trial.
    BMJ. 2023;382:e070464.
    

    >> Share

    
    
52. DYER O
    Covid-19: Drug companies charged South Africa high prices for vaccines, contracts reveal.
    BMJ. 2023;382:2112.
    

    >> Share

    
    
53. ALTMANN DM, Boyton RJ
    Outsourcing covid-19 vaccination to the private sector will increase health inequalities.
    BMJ. 2023;382:2012.
    

    >> Share

    
    August 2023
54. 
    The UK government needs to expand covid-19 vaccination this winter.
    BMJ. 2023;382:p2006.
    

    >> Share

    
    
55. FORTNER R
    Polio vaccines: hope, hype, and history repeating?
    BMJ. 2023;382:p1763.
    

    >> Share

    
    
56. MAHASE E
    Covid-19: Payment to general practices to deliver vaccines to be cut by 25.
    BMJ. 2023;382:1821.
    

    >> Share

    
    
57. DE AMBROSIO M
    Covid-19: Latin America defies nationalism and circumstance to develop its own vaccines.
    BMJ. 2023;382:1351.
    

    >> Share

    
    July 2023
58. LIMB M
    Alarming decline in vaccine update must be tackled, say MPs.
    BMJ. 2023;382:p1741.
    

    >> Share

    
    
59. ANDERSSON NW, Thiesson EM, Hansen JV, Hviid A, et al
    Safety of BA.4-5 or BA.1 bivalent mRNA booster vaccines: nationwide cohort study.
    BMJ. 2023;382:e075015.
    

    >> Share

    
    
60. ANDERSSON NW, Thiesson EM, Baum U, Pihlstrom N, et al
    Comparative effectiveness of bivalent BA.4-5 and BA.1 mRNA booster vaccines among adults aged >/=50 years in Nordic countries: nationwide cohort study.
    BMJ. 2023;382:e075286.
    

    >> Share

    
    
61. 
    Why older adults can continue to benefit from covid-19 boosters.
    BMJ. 2023;382:p1662.
    

    >> Share

    
    
62. ANDERSSON NW, Thiesson EM, Baum U, Pihlstrom N, et al
    Comparative effectiveness of heterologous third dose vaccine schedules against severe covid-19 during omicron predominance in Nordic countries: population based cohort analyses.
    BMJ. 2023;382:e074325.
    

    >> Share

    
    
63. HOUSTON AR, Liu J, Habibi R, Murthy S, et al
    Canada's role in covid-19 global vaccine equity failures.
    BMJ. 2023;382:e075149.
    

    >> Share

    
    
64. DYER C
    GP is struck off after comments made to parents about vaccines.
    BMJ. 2023;382:p1581.
    

    >> Share

    
    
65. IACOBUCCI G, Kmietowicz Z
    Doctor launches legal challenge over GMC's failure to investigate fellow medic's covid vaccine claims.
    BMJ. 2023;382:p1568.
    

    >> Share

    
    
66. WILDE H, Tomlinson C, Mateen BA, Selby D, et al
    Hospital admissions linked to SARS-CoV-2 infection in children and adolescents: cohort study of 3.2 million first ascertained infections in England.
    BMJ. 2023;382:e073639.
    

    >> Share

    
    June 2023
67. IACOBUCCI G
    GPs predict "fourfold increase" in work to administer expanded shingles vaccination.
    BMJ. 2023;381:p1493.
    

    >> Share

    
    
68. HIPPISLEY-COX J, Khunti K, Sheikh A, Nguyen-Van-Tam JS, et al
    Risk prediction of covid-19 related death or hospital admission in adults testing positive for SARS-CoV-2 infection during the omicron wave in England (QCOVID4): cohort study.
    BMJ. 2023;381:e072976.
    

    >> Share

    
    
69. MALHOTRA S
    India investigates alleged leak of personal data from covid vaccination database.
    BMJ. 2023;381:1407.
    

    >> Share

    
    
70. MAHASE E
    England's HPV vaccine programme will move to a single dose from September.
    BMJ. 2023;381:1423.
    

    >> Share

    
    
71. BUSHKOVSKA N
    Vaccination in the war in Ukraine.
    BMJ. 2023;381:p963.
    

    >> Share

    
    
72. ZIMAKOFF AC, Jensen A, Vittrup DM, Herlufsen EH, et al
    Measles, mumps, and rubella vaccine at age 6 months and hospitalisation for infection before age 12 months: randomised controlled trial.
    BMJ. 2023;381:e072724.
    

    >> Share

    
    
73. MONGE S, Pastor-Barriuso R, Hernan MA
    The imprinting effect of covid-19 vaccines: an expected selection bias in observational studies.
    BMJ. 2023;381:e074404.
    

    >> Share

    
    May 2023
74. COOMBES R
    Doctors launch bid to challenge GMC over its failure to act on "high profile doctors" who spread vaccine misinformation.
    BMJ. 2023;381:1220.
    

    >> Share

    
    
75. KUNDI M
    Vaccine effectiveness against delta and omicron variants of SARS-CoV-2.
    BMJ. 2023;381:p1111.
    

    >> Share

    
    
76. BOHNERT AS, Kumbier K, Rowneki M, Gupta A, et al
    Adverse outcomes of SARS-CoV-2 infection with delta and omicron variants in vaccinated versus unvaccinated US veterans: retrospective cohort study.
    BMJ. 2023;381:e074521.
    

    >> Share

    
    
77. BOYTCHEV H
    FDA advisers back Pfizer's maternal RSV vaccine after voicing safety concerns.
    BMJ. 2023;381:p1187.
    

    >> Share

    
    
78. TAYLOR A, Male V
    Covid-19 vaccination and postmenopausal bleeding.
    BMJ. 2023;381:p1122.
    

    >> Share

    
    
79. ALAKIJA A
    Vaccine manufacturing in Africa.
    BMJ. 2023;381:908.
    

    >> Share

    
    
80. BOYTCHEV H
    Maternal RSV vaccine: Further analysis is urged on preterm births.
    BMJ. 2023;381:1021.
    

    >> Share

    
    
81. VAN DER LINDEN S
    We need a gold standard for randomised control trials studying misinformation and vaccine hesitancy on social media.
    BMJ. 2023;381:1007.
    

    >> Share

    
    
82. LJUNG R, Xu Y, Sundstrom A, Leach S, et al
    Association between SARS-CoV-2 vaccination and healthcare contacts for menstrual disturbance and bleeding in women before and after menopause: nationwide, register based cohort study.
    BMJ. 2023;381:e074778.
    

    >> Share

    
    April 2023
83. WISE J
    First RSV vaccine for older adults is approved in Europe.
    BMJ. 2023;381:978.
    

    >> Share

    
    
84. XIE Y, Choi T, Al-Aly Z
    Molnupiravir and risk of post-acute sequelae of covid-19: cohort study.
    BMJ. 2023;381:e074572.
    

    >> Share

    
    
85. DYER C
    NHS psychologist died after rare reaction to AstraZeneca vaccine, rules coroner.
    BMJ. 2023;381:p907.
    

    >> Share

    
    
86. MAHASE E
    Ghana approves Oxford's malaria vaccine for children aged 5 to 36 months.
    BMJ. 2023;381:850.
    

    >> Share

    
    
87. BARNES-WEISE J, Hoemeke L, Telford B
    Public investment in the development of vaccines: providing equitable access around the world.
    BMJ. 2023;381:p743.
    

    >> Share

    
    March 2023
88. FEINMANN J
    Cholera makes a comeback amid calls to boost vaccine production.
    BMJ. 2023;380:636.
    

    >> Share

    
    
89. MAHASE E
    Covid-19: Study reports no significant increase in deaths after vaccination but raises questions over AstraZeneca's vaccine.
    BMJ. 2023;380:741.
    

    >> Share

    
    
90. DYER C
    Patients launch legal action against AstraZeneca over its covid-19 vaccine.
    BMJ. 2023;380:725.
    

    >> Share

    
    
91. HULME WJ, Horne EMF, Parker EPK, Keogh RH, et al
    Comparative effectiveness of BNT162b2 versus mRNA-1273 covid-19 vaccine boosting in England: matched cohort study in OpenSAFELY-TPP.
    BMJ. 2023;380:e072808.
    

    >> Share

    
    
92. 
    US public investment in development of mRNA covid-19 vaccines: retrospective cohort study.
    BMJ. 2023;380:p587.
    

    >> Share

    
    
93. MAHASE E
    H5N1: Has there been human-to-human transmission, and do we have a vaccine?
    BMJ. 2023;380:p510.
    

    >> Share

    
    
94. LALANI HS, Nagar S, Sarpatwari A, Barenie RE, et al
    US public investment in development of mRNA covid-19 vaccines: retrospective cohort study.
    BMJ. 2023;380:e073747.
    

    >> Share

    
    
95. ROY V
    Financing covid-19 mRNA vaccines.
    BMJ. 2023;380:p413.
    

    >> Share

    
    
96. TAYLOR L
    Covid-19: Vaccination reduces severity and duration of long covid, study finds.
    BMJ. 2023;380:p491.
    

    >> Share

    
    February 2023
97. MAHASE E
    H5N1: Governments should invest in vaccines for all flu strains, says incoming WHO chief scientist.
    BMJ. 2023;380:p434.
    

    >> Share

    
    
98. DANINO D, Youngster I
    Protecting infants through covid-19 vaccination during pregnancy.
    BMJ. 2023;380:p241.
    

    >> Share

    
    
99. JORGENSEN SCJ, Hernandez A, Fell DB, Austin PC, et al
    Maternal mRNA covid-19 vaccination during pregnancy and delta or omicron infection or hospital admission in infants: test negative design study.
    BMJ. 2023;380:e074035.
    

    >> Share

    
    January 2023
100. MAHASE E
     Covid-19: JCVI recommends autumn vaccine booster for the most vulnerable.
     BMJ. 2023;380:204.
     

     >> Share

     
     
101. TORJESEN I
     Covid-19: Vaccination plus infection offers best protection, finds study led by WHO.
     BMJ. 2023;380:p171.
     

     >> Share

     
     
102. DYER O
     Covid-19: Florida's surgeon general used "careless" research practice in recommending against vaccination, his university finds.
     BMJ. 2023;380:p110.
     

     >> Share

     
     
103. IACOBUCCI G
     Covid-19: Tory MP is suspended after comparing vaccines to holocaust.
     BMJ. 2023;380:p81.
     

     >> Share

     
     
104. BARANIUK C
     When will the world get cancer vaccines?
     BMJ. 2023;380:o3041.
     

     >> Share

     
     
105. LAZARUS JV, Karim SSA, Batista C, Rabin K, et al
     Vaccine inequity and hesitancy persist-we must tackle both.
     BMJ. 2023;380:p8.
     

     >> Share

     
     December 2022
106. YAMEY G
     Why is Florida's governor ramping up his anti-vaccine rhetoric?
     BMJ. 2022;379:o3061.
     

     >> Share

     
     
107. WISE J
     Covid-19: Molnupiravir does not cut hospital admissions or deaths in vaccinated people at high risk, trial finds.
     BMJ. 2022;379:o3055.
     

     >> Share

     
     
108. PAYTUBI S, Benavente Y, Montoliu A, Binefa G, et al
     Everything causes cancer? Beliefs and attitudes towards cancer prevention among anti-vaxxers, flat earthers, and reptilian conspiracists: online cross sectional survey.
     BMJ. 2022;379:e072561.
     

     >> Share

     
     
109. FLORENTINO PTV, Cerqueira-Silva T, Barral-Netto M, Paixao ES, et al
     Effectiveness of covid-19 vaccines in adolescents and children.
     BMJ. 2022;379:o3018.
     

     >> Share

     
     
110. RAHANGDALE L, Mungo C, O'Connor S, Chibwesha CJ, et al
     Human papillomavirus vaccination and cervical cancer risk.
     BMJ. 2022;379:e070115.
     

     >> Share

     
     
111. TALYOR L
     Haiti: Hospitals face critical oxygen shortages and warn of lack of fluids to treat cholera.
     BMJ. 2022;379:o2961.
     

     >> Share

     
     
112. 
     AstraZeneca's covid-19 (mis)adventure and the future of vaccine equity.
     BMJ. 2022;379:o2954.
     

     >> Share

     
     
113. 
     Update to living systematic review on effectiveness of heterologous and homologous covid-19 vaccine regimens.
     BMJ. 2022;379:o2865.
     

     >> Share

     
     November 2022
114. CASTELLI JM, Rearte A, Olszevicki S, Voto C, et al
     Effectiveness of mRNA-1273, BNT162b2, and BBIBP-CorV vaccines against infection and mortality in children in Argentina, during predominance of delta and omicron covid-19 variants: test negative, case-control study.
     BMJ. 2022;379:e073070.
     

     >> Share

     
     
115. IACOBUCCI G
     Ministers plan to replicate vaccine task force for cancer, obesity, mental health, and addiction.
     BMJ. 2022;379:o2880.
     

     >> Share

     
     
116. MAHASE E
     Monkeypox: Single dose of smallpox vaccine offers 78% protection, UKHSA reports.
     BMJ. 2022;379:o2829.
     

     >> Share

     
     
117. FORTNER R
     AstraZeneca's covid-19 (mis)adventure and the future of vaccine equity.
     BMJ. 2022;379:o2592.
     

     >> Share

     
     
118. MAHASE E
     Vaccine access: World's poorest people suffer at the hands of free market dynamics, says WHO.
     BMJ. 2022;379:o2714.
     

     >> Share

     
     
119. UPTON MN
     Covid-19 vaccination in the UK: the Joint Committee on Vaccination and Immunisation's infrastructure.
     BMJ. 2022;379:o2685.
     

     >> Share

     
     
120. O'DOWD A
     Flu: Public urged to get vaccinated in face of possible surge of infections this winter.
     BMJ. 2022;379:o2655.
     

     >> Share

     
     October 2022
121. 
     FDA urged to publish follow-up studies on covid-19 vaccine safety signals.
     BMJ. 2022;379:o2593.
     

     >> Share

     
     
122. WASSWA H
     Ebola: Uganda plans trials of two vaccines as cases rise.
     BMJ. 2022;379:o2589.
     

     >> Share

     
     
123. LI X, Burn E, Duarte-Salles T, Yin C, et al
     Comparative risk of thrombosis with thrombocytopenia syndrome or thromboembolic events associated with different covid-19 vaccines: international network cohort study from five European countries and the US.
     BMJ. 2022;379:e071594.
     

     >> Share

     
     
124. DEMASI M
     FDA urged to publish follow-up studies on covid-19 vaccine safety signals.
     BMJ. 2022;379:o2527.
     

     >> Share

     
     
125. TAYLOR L
     Cholera: WHO rations vaccines to preserve stocks amid rising outbreaks.
     BMJ. 2022;379:o2528.
     

     >> Share

     
     
126. 
     What next for covid-19 vaccines?
     BMJ. 2022;379:o2535.
     

     >> Share

     
     
127. LOOI MK, Mahase E
     What next for covid-19 vaccines?
     BMJ. 2022;379:o2422.
     

     >> Share

     
     
128. MAHASE E
     Covid-19: Booster vaccines rolled out as hospital admissions rise.
     BMJ. 2022;379:o2484.
     

     >> Share

     
     
129. HOTEZ PJ, Matshaba M
     Promise of new malaria vaccines.
     BMJ. 2022;379:o2462.
     

     >> Share

     
     
130. ADAMS K, Rhoads JP, Surie D, Gaglani M, et al
     Vaccine effectiveness of primary series and booster doses against covid-19 associated hospital admissions in the United States: living test negative design study.
     BMJ. 2022;379:e072065.
     

     >> Share

     
     
131. SCHWALBE N, Varma JK
     The US needs to prepare to introduce the novel oral polio vaccine.
     BMJ. 2022;379:o2388.
     

     >> Share

     
     
132. FERDINANDS JM, Rao S, Dixon BE, Mitchell PK, et al
     Waning of vaccine effectiveness against moderate and severe covid-19 among adults in the US from the VISION network: test negative, case-control study.
     BMJ. 2022;379:e072141.
     

     >> Share

     
     September 2022
133. IACOBUCCI G
     UK childhood vaccination rates fell last year in almost all programmes, figures show.
     BMJ. 2022;378:o2353.
     

     >> Share

     
     
134. MAJEED A, Pollock K, Hodes S, Papaluca M, et al
     Implementation of covid-19 vaccination in the United Kingdom.
     BMJ. 2022;378:e070344.
     

     >> Share

     
     
135. TAYLOR L
     Covid-19: PAHO calls for Americas to reverse vaccination setbacks caused by pandemic.
     BMJ. 2022;378:o2344.
     

     >> Share

     
     
136. MAHASE E
     Parents are urged to vaccinate 2-3 year olds against flu as NHS warns of "twindemic".
     BMJ. 2022;378:o2335.
     

     >> Share

     
     
137. THIAGARAJAN K
     Why did rabies control fail in India?
     BMJ. 2022;378:o2284.
     

     >> Share

     
     August 2022
138. MAHASE E
     Monkeypox: Fractional vaccine doses will be piloted as new treatment trial launches.
     BMJ. 2022;378:o2080.
     

     >> Share

     
     
139. COX D
     What do we know about covid-19 vaccines in under 5s?
     BMJ. 2022;378:o1892.
     

     >> Share

     
     
140. WISE J
     Monkeypox: UK to run out of vaccine doses by next week.
     BMJ. 2022;378:o2053.
     

     >> Share

     
     
141. MAHASE E
     Covid-19: UK will roll out Moderna's omicron BA.1 vaccine as part of autumn booster programme.
     BMJ. 2022;378:o2038.
     

     >> Share

     
     
142. FELL DB, Dimanlig-Cruz S, Regan AK, Haberg SE, et al
     Risk of preterm birth, small for gestational age at birth, and stillbirth after covid-19 vaccination during pregnancy: population based retrospective cohort study.
     BMJ. 2022;378:e071416.
     

     >> Share

     
     
143. WISE J
     Covid-19: Study provides further evidence that mRNA vaccines are safe in pregnancy.
     BMJ. 2022;378:o2013.
     

     >> Share

     
     
144. HUSSAIN Z
     Polio vaccine is offered to all children in London aged 1 to 9 after virus detected in sewage.
     BMJ. 2022;378:o2007.
     

     >> Share

     
     
145. BADELL ML, Dude CM, Rasmussen SA, Jamieson DJ, et al
     Covid-19 vaccination in pregnancy.
     BMJ. 2022;378:e069741.
     

     >> Share

     
     
146. TAYLOR L
     Monkeypox: Concerns mount over vaccine inequity.
     BMJ. 2022;378:o1971.
     

     >> Share

     
     
147. KECHAGIAS KS, Kalliala I, Bowden SJ, Athanasiou A, et al
     Role of human papillomavirus (HPV) vaccination on HPV infection and recurrence of HPV related disease after local surgical treatment: systematic review and meta-analysis.
     BMJ. 2022;378:e070135.
     

     >> Share

     
     July 2022
148. SAXENA S, Skirrow H, Wighton K
     Vaccinating children aged under 5 years against covid-19.
     BMJ. 2022;378:o1863.
     

     >> Share

     
     
149. HORNE EMF, Hulme WJ, Keogh RH, Palmer TM, et al
     Waning effectiveness of BNT162b2 and ChAdOx1 covid-19 vaccines over six months since second dose: OpenSAFELY cohort study using linked electronic health records.
     BMJ. 2022;378:e071249.
     

     >> Share

     
     
150. POPLE D, Monk EJM, Evans S, Foulkes S, et al
     Burden of SARS-CoV-2 infection in healthcare workers during second wave in England and impact of vaccines: prospective multicentre cohort study (SIREN) and mathematical model.
     BMJ. 2022;378:e070379.
     

     >> Share

     
     
151. BREATHNACH AS
     Rapid covid-19 vaccination for health workers.
     BMJ. 2022;378:o1674.
     

     >> Share

     
     
152. HULME WJ, Williamson EJ, Green ACA, Bhaskaran K, et al
     Comparative effectiveness of ChAdOx1 versus BNT162b2 covid-19 vaccines in health and social care workers in England: cohort study using OpenSAFELY.
     BMJ. 2022;378:e068946.
     

     >> Share

     
     
153. ANDERSSON NW, Thiesson EM, Laursen MV, Mogensen SH, et al
     Safety of heterologous primary and booster schedules with ChAdOx1-S and BNT162b2 or mRNA-1273 vaccines: nationwide cohort study.
     BMJ. 2022;378:e070483.
     

     >> Share

     
     
154. REZA HM, Agarwal V, Sultana F, Bari R, et al
     Why are vaccination rates lower in low and middle income countries, and what can we do about it?
     BMJ. 2022;378:e069506.
     

     >> Share

     
     
155. WISE J
     Covid-19: MPs call for greater efforts to reach the unvaccinated and partially vaccinated.
     BMJ. 2022;378:o1743.
     

     >> Share

     
     
156. PILLAY J, Gaudet L, Wingert A, Bialy L, et al
     Incidence, risk factors, natural history, and hypothesised mechanisms of myocarditis and pericarditis following covid-19 vaccination: living evidence syntheses and review.
     BMJ. 2022;378:e069445.
     

     >> Share

     
     
157. BLOCK J
     Covid-19: Researchers face wait for patient level data from Pfizer and Moderna vaccine trials.
     BMJ. 2022;378:o1731.
     

     >> Share

     
     
158. DYER O
     Covid vaccines: Canada to dispose of 13.6 million AstraZeneca doses owing to lack of demand.
     BMJ. 2022;378:o1700.
     

     >> Share

     
     
159. GREWAL R, Kitchen SA, Nguyen L, Buchan SA, et al
     Effectiveness of a fourth dose of covid-19 mRNA vaccine against the omicron variant among long term care residents in Ontario, Canada: test negative design study.
     BMJ. 2022;378:e071502.
     

     >> Share

     
     
160. WILKINSON E
     Covid-19: GPs are asked to opt into next vaccination phase this autumn.
     BMJ. 2022;378:o1657.
     

     >> Share

     
     
161. SAUL H, Gursul D, Antonelli M, Steves C, et al
     Frail older people and those in deprived areas remain at risk from covid-19, even after vaccination.
     BMJ. 2022;378:o1313.
     

     >> Share

     
     June 2022
162. CLARKE E, Kampmann B
     No one is safe until everyone is safe-from polio too.
     BMJ. 2022;377:o1625.
     

     >> Share

     
     
163. MAHASE E
     Polio: What do we know about the polioviruses detected in the UK?
     BMJ. 2022;377:o1578.
     

     >> Share

     
     
164. WISE J
     Covid-19: UK makes first payments to compensate injury or death from vaccines.
     BMJ. 2022;377:o1565.
     

     >> Share

     
     
165. WISE J
     Moderna to open mRNA vaccine research and manufacturing centre in the UK.
     BMJ. 2022;377:o1556.
     

     >> Share

     
     
166. MAHASE E
     Monkeypox: Gay and bisexual men with high exposure risk will be offered vaccine in England.
     BMJ. 2022;377:o1542.
     

     >> Share

     
     
167. TANNE JH
     Covid-19: CDC and FDA approve Pfizer and Moderna vaccines for under 5s.
     BMJ. 2022;377:o1507.
     

     >> Share

     
     
168. SAXENA S, Skirrow H, Maini A, Hayhoe B, et al
     Consenting children aged under 18 for vaccination and treatment.
     BMJ. 2022;377:e068889.
     

     >> Share

     
     
169. HITCHINGS MDT, Ranzani OT, Lind ML, Dorion M, et al
     Change in covid-19 risk over time following vaccination with CoronaVac: test negative case-control study.
     BMJ. 2022;377:e070102.
     

     >> Share

     
     
170. MAZZILLI S, Moazen B, Stover H, Plugge E, et al
     Covid-19 vaccine in prison: a not-to-be-missed opportunity to promote access to vaccination in adolescents.
     BMJ. 2022;377:o1439.
     

     >> Share

     
     
171. STOKEL-WALKER C
     How are vaccines being adapted to meet the changing face of SARS-CoV-2?
     BMJ. 2022;377:o1257.
     

     >> Share

     
     
172. MAHASE E
     Monkeypox: Healthcare workers will be offered smallpox vaccine as UK buys 20 000 doses.
     BMJ. 2022;377:o1379.
     

     >> Share

     
     May 2022
173. AU WY, Cheung PP
     Effectiveness of heterologous and homologous covid-19 vaccine regimens: living systematic review with network meta-analysis.
     BMJ. 2022;377:e069989.
     

     >> Share

     
     
174. BRYCE E, Ong S
     Covid-19 and mRNA technology are helping Africa fix its vaccine problems.
     BMJ. 2022;377:o1196.
     

     >> Share

     
     
175. WISE J
     Covid-19: Vaccine effectiveness wanes more rapidly for cancer patients, study finds.
     BMJ. 2022;377:o1305.
     

     >> Share

     
     
176. GAZIT S, Saciuk Y, Perez G, Peretz A, et al
     Short term, relative effectiveness of four doses versus three doses of BNT162b2 vaccine in people aged 60 years and older in Israel: retrospective, test negative, case-control study.
     BMJ. 2022;377:e071113.
     

     >> Share

     
     
177. HORDIJK L, Patnaik P
     Covid-19-How Europe's vaccine donations went tragically wrong.
     BMJ. 2022;377:o1286.
     

     >> Share

     
     
178. WISE J
     NICE publishes guidance to increase uptake of routine vaccinations.
     BMJ. 2022;377:o1260.
     

     >> Share

     
     
179. SIVAN M, Greenhalgh T, Milne R, Delaney B, et al
     Are vaccines a potential treatment for long covid?
     BMJ. 2022;377:o988.
     

     >> Share

     
     
180. HOANG U, de Lusignan S, Joy M, Sherlock J, et al
     Future reporting of vaccine uptake needs to include any change in ethnic or socioeconomic disparities.
     BMJ. 2022;377:o1233.
     

     >> Share

     
     
181. AYOUBKHANI D, Bermingham C, Pouwels KB, Glickman M, et al
     Trajectory of long covid symptoms after covid-19 vaccination: community based cohort study.
     BMJ. 2022;377:e069676.
     

     >> Share

     
     
182. IACOBUCCI G
     Covid-19: Fourth dose of mRNA vaccines is safe and boosts immunity, study finds.
     BMJ. 2022;377:o1170.
     

     >> Share

     
     
183. KWAN R
     How Hong Kong's vaccination missteps led to the world's highest covid-19 death rate.
     BMJ. 2022;377:o1127.
     

     >> Share

     
     
184. MAHASE E
     Sixty seconds on . . . nasal vaccines.
     BMJ. 2022;377:o1148.
     

     >> Share

     
     
185. MAHASE E
     Hepatitis: Ukrainian refugees should be offered vaccines and free treatment, says WHO.
     BMJ. 2022;377:o1132.
     

     >> Share

     
     
186. USTIANOWSKI A
     Why covid vaccine studies are still needed.
     BMJ. 2022;377:o1135.
     

     >> Share

     
     April 2022
187. BERDZULI N, Datta SS
     How to tackle inequitable access, vaccine hesitancy, and other barriers to achieve high vaccine uptake.
     BMJ. 2022;377:o1094.
     

     >> Share

     
     
188. WISE J
     Covid-19: Drug companies urged to share vaccine technology to boost equity and access.
     BMJ. 2022;377:o1086.
     

     >> Share

     
     
189. 
     Covid-19: Is the US compensation scheme for vaccine injuries fit for purpose?
     BMJ. 2022;377:o1073.
     

     >> Share

     
     
190. SUTHAR AB, Wang J, Seffren V, Wiegand RE, et al
     Public health impact of covid-19 vaccines in the US: observational study.
     BMJ. 2022;377:e069317.
     

     >> Share

     
     
191. DYE C
     The benefits of large scale covid-19 vaccination.
     BMJ. 2022;377:o867.
     

     >> Share

     
     
192. LOOI MK
     The BMJ Interview: WHO chief scientist optimistic for a pan-coronavirus vaccine in two years.
     BMJ. 2022;377:o1003.
     

     >> Share

     
     
193. MAHASE E
     Covid-19: Mix and match booster vaccination approach offers best protection, study reports.
     BMJ. 2022;377:o1052.
     

     >> Share

     
     
194. DEMASI M
     Covid-19: Is the US compensation scheme for vaccine injuries fit for purpose?
     BMJ. 2022;377:o919.
     

     >> Share

     
     
195. MAHASE E
     Meningitis vaccine could protect against gonorrhoea, studies find.
     BMJ. 2022;377:o997.
     

     >> Share

     
     
196. MAHASE E
     Covid-19: UK approves Valneva vaccine for adults under 50.
     BMJ. 2022;377:o985.
     

     >> Share

     
     
197. MA A, Parry J
     When Hong Kong's "dynamic zero" covid-19 strategy met omicron, low vaccination rates sent deaths soaring.
     BMJ. 2022;377:o980.
     

     >> Share

     
     
198. WILLICOMBE M, Scanlon M, Loud F, Lightstone L, et al
     Should we be clinically assessing antibody responses to covid vaccines in immunocompromised people?
     BMJ. 2022;377:o966.
     

     >> Share

     
     
199. KILDEGAARD H, Lund LC, Hojlund M, Stensballe LG, et al
     Risk of adverse events after covid-19 in Danish children and adolescents and effectiveness of BNT162b2 in adolescents: cohort study.
     BMJ. 2022;377:e068898.
     

     >> Share

     
     
200. TSAGKARIS C, Laubscher L, Vladychuk V
     Vaccine wastage as collateral damage in Ukrainian conflict.
     BMJ. 2022;377:o911.
     

     >> Share

     
     
201. BINAGWAHO A, Mathewos K
     Rwanda's success in rolling out its covid-19 vaccination campaign is a lesson to us all.
     BMJ. 2022;377:o881.
     

     >> Share

     
     March 2022
202. LOOI MK
     Disincentives for vaccine refusal.
     BMJ. 2022;376:o865.
     

     >> Share

     
     
203. SMITH MA, Sherrah M, Sultana F, Castle PE, et al
     National experience in the first two years of primary human papillomavirus (HPV) cervical screening in an HPV vaccinated population in Australia: observational study.
     BMJ. 2022;376:e068582.
     

     >> Share

     
     
204. MAJEED A, Tessier E, Stowe J, Mokdad AH, et al
     How data from the United Kingdom has guided covid-19 vaccine policies.
     BMJ. 2022;376:o839.
     

     >> Share

     
     
205. KAMAL-YANNI M, Cueni T
     Should covid-19 vaccines and drugs be "not for profit"?
     BMJ. 2022;376:o755.
     

     >> Share

     
     
206. HOWARD S, Krishna G
     The world's refugees remain last in line for covid-19 vaccines.
     BMJ. 2022;376:o703.
     

     >> Share

     
     
207. DYER O
     Covid-19: WHO set to reject Canadian plant based vaccine because of links with tobacco industry.
     BMJ. 2022;376:o811.
     

     >> Share

     
     
208. HATALA A, Pervaiz MC, Handley R, Vijayan T, et al
     Faith based dialogue can tackle vaccine hesitancy and build trust.
     BMJ. 2022;376:o823.
     

     >> Share

     
     
209. 
     It is not too late to achieve global covid-19 vaccine equity.
     BMJ. 2022;376:o812.
     

     >> Share

     
     
210. TANNE JH
     Covid-19: Moderna will ask for authorisation for vaccine for infants and children.
     BMJ. 2022;376:o798.
     

     >> Share

     
     
211. BERKLEY S
     Ending the covid-19 pandemic means helping countries to catch-up with vaccination, not giving up.
     BMJ. 2022;376:o786.
     

     >> Share

     
     
212. YAMEY G, Garcia P, Hassan F, Mao W, et al
     It is not too late to achieve global covid-19 vaccine equity.
     BMJ. 2022;376:e070650.
     

     >> Share

     
     
213. GUEST JL
     The US shouldn't settle for its current number of covid deaths or vaccination rates.
     BMJ. 2022;376:o763.
     

     >> Share

     
     
214. TANNE JH
     Covid-19: Pfizer asks US regulator to authorise fourth vaccine dose for over 65s.
     BMJ. 2022;376:o711.
     

     >> Share

     
     
215. WILKINSON E
     Covid-19: Doctors urge government to step up on global vaccine funding.
     BMJ. 2022;376:o709.
     

     >> Share

     
     
216. LI X, Raventos B, Roel E, Pistillo A, et al
     Association between covid-19 vaccination, SARS-CoV-2 infection, and risk of immune mediated neurological events: population based cohort and self-controlled case series analysis.
     BMJ. 2022;376:e068373.
     

     >> Share

     
     
217. POTTEGARD A, Klungel OH
     The neurological safety of covid-19 vaccines.
     BMJ. 2022;376:o522.
     

     >> Share

     
     
218. TINARI S
     Covid-19: Ukraine conflict calls Russia's vaccine diplomacy into question.
     BMJ. 2022;376:o626.
     

     >> Share

     
     
219. LAURING AS, Tenforde MW, Chappell JD, Gaglani M, et al
     Clinical severity of, and effectiveness of mRNA vaccines against, covid-19 from omicron, delta, and alpha SARS-CoV-2 variants in the United States: prospective observational study.
     BMJ. 2022;376:e069761.
     

     >> Share

     
     
220. MAHASE E
     Covid-19: Coalition pledges $42m to develop broad protection vaccine against betacoronaviruses.
     BMJ. 2022;376:o628.
     

     >> Share

     
     
221. DYER O
     Covid-19: Florida surgeon general says state will be first not to recommend vaccination for children.
     BMJ. 2022;376:o622.
     

     >> Share

     
     
222. MAHASE E
     Covid-19: Public vaccine funding needs "strings attached" for equitable access, say campaigners.
     BMJ. 2022;376:o565.
     

     >> Share

     
     
223. LEE ARYB, Wong SY, Chai LYA, Lee SC, et al
     Efficacy of covid-19 vaccines in immunocompromised patients: systematic review and meta-analysis.
     BMJ. 2022;376:e068632.
     

     >> Share

     
     February 2022
224. TAYLOR L
     Covid-19: Lagging vaccination leaves the Caribbean vulnerable, says PAHO.
     BMJ. 2022;376:o519.
     

     >> Share

     
     
225. MAHASE E
     Covid-19: Sanofi and GSK to seek regulatory authorisation for protein based vaccine.
     BMJ. 2022;376:o526.
     

     >> Share

     
     
226. IACOBUCCI G
     Covid-19: Vaccine programme a success, but staff burnout is a major risk, auditors warn.
     BMJ. 2022;376:o493.
     

     >> Share

     
     
227. WIESELER B
     Covid-19 vaccines: individual patient data should be submitted to the European Medicines Agency.
     BMJ. 2022;376:o417.
     

     >> Share

     
     
228. GLOVER RE, Roberts AP, Singer AC, Kirchhelle C, et al
     Sale of UK's Vaccine Manufacturing and Innovation Centre.
     BMJ. 2022;376:e069999.
     

     >> Share

     
     
229. ENNOS RA
     Covid-19 vaccines: we need immediate release of anonymised data from yellow card scheme.
     BMJ. 2022;376:o414.
     

     >> Share

     
     
230. IACOBUCCI G
     Covid-19: Antibodies after AstraZeneca and Pfizer vaccines decrease with age and are higher in women, data show.
     BMJ. 2022;376:o428.
     

     >> Share

     
     
231. LOPES H, McCallum A, Martin-Moreno JM, Middleton J, et al
     Invest in primary healthcare and public health for the pandemic and beyond.
     BMJ. 2022;376:o425.
     

     >> Share

     
     
232. WISE J
     Covid-19: Vaccine will be offered to 5-11 year olds in England, Wales, and Scotland.
     BMJ. 2022;376:o411.
     

     >> Share

     
     
233. MAHASE E
     Covid-19: Vaccinated people are less likely to get long covid, review finds.
     BMJ. 2022;376:o407.
     

     >> Share

     
     
234. MAHASE E
     Covid-19: Solely refusing vaccine will not trigger a fitness to practise investigation, says GMC.
     BMJ. 2022;376:o372.
     

     >> Share

     
     
235. LOSEVA P
     Data and distrust hamper Russia's vaccination programme.
     BMJ. 2022;376:o321.
     

     >> Share

     
     
236. WILKINSON E
     Is anti-vaccine sentiment affecting routine childhood immunisations?
     BMJ. 2022;376:o360.
     

     >> Share

     
     
237. FABIANI M, Puopolo M, Morciano C, Spuri M, et al
     Effectiveness of mRNA vaccines and waning of protection against SARS-CoV-2 infection and severe covid-19 during predominant circulation of the delta variant in Italy: retrospective cohort study.
     BMJ. 2022;376:e069052.
     

     >> Share

     
     
238. MCKEE M, van Schalkwyk MCI
     England's U turn on covid-19 vaccine mandate for NHS staff.
     BMJ. 2022;376:o353.
     

     >> Share

     
     
239. DAVIES M
     Covid-19: WHO efforts to bring vaccine manufacturing to Africa are undermined by the drug industry, documents show.
     BMJ. 2022;376:o304.
     

     >> Share

     
     
240. IACOBUCCI G
     Covid-19: Medical regulators should ensure that health workers are vaccinated, says Javid.
     BMJ. 2022;376:o346.
     

     >> Share

     
     
241. HODES S, Stanley S, Majeed A
     A national vaccination service for the NHS in England: a proposal to be considered with caution.
     BMJ. 2022;376:o338.
     

     >> Share

     
     
242. ARONSON JK
     When I use a word . . . . Vaccination-rights and duties.
     BMJ. 2022;376:o317.
     

     >> Share

     
     
243. STOKEL-WALKER C
     What do we know about covid vaccines and preventing transmission?
     BMJ. 2022;376:o298.
     

     >> Share

     
     
244. WISE J
     Covid-19: UK approves Novavax's protein based vaccine.
     BMJ. 2022;376:o309.
     

     >> Share

     
     
245. DYER C
     Covid-19: Vulnerable adult must be vaccinated against parents' wishes, judge rules.
     BMJ. 2022;376:o308.
     

     >> Share

     
     
246. THORNTON J
     Covid-19: Trust in government and other people linked with lower infection rate and higher vaccination uptake.
     BMJ. 2022;376:o292.
     

     >> Share

     
     
247. IACOBUCCI G
     Covid-19: Government abandons mandatory vaccination of NHS staff.
     BMJ. 2022;376:o269.
     

     >> Share

     
     January 2022
248. HAWKSBEE L, McKee M, King L
     Don't worry about the drug industry's profits when considering a waiver on covid-19 intellectual property rights.
     BMJ. 2022;376:e067367.
     

     >> Share

     
     
249. KMIETOWICZ Z
     Covid-19: Halt mandatory vaccination to keep England's maternity services safe, pleads royal college.
     BMJ. 2022;376:o249.
     

     >> Share

     
     
250. TORJESEN I
     Covid-19: Lower vaccination rates partly explain higher death rates among minority ethnic groups.
     BMJ. 2022;376:o233.
     

     >> Share

     
     
251. FREER J, Mudaly V
     HIV and covid-19 in South Africa.
     BMJ. 2022;376:e069807.
     

     >> Share

     
     
252. FIALEK B
     On the verge of Poland's fifth wave of covid-19, healthcare staff are overworked and disenchanted.
     BMJ. 2022;376:o234.
     

     >> Share

     
     
253. TAYLOR L
     Covid-19: Cuba will request WHO approval for homegrown vaccine.
     BMJ. 2022;376:o230.
     

     >> Share

     
     
254. MALE V
     Menstruation and covid-19 vaccination.
     BMJ. 2022;376:o142.
     

     >> Share

     
     
255. TAYLOR L
     Covid-19: CoronaVac immunity is strongest after boosting with a different vaccine.
     BMJ. 2022;376:o210.
     

     >> Share

     
     
256. SOKOL D
     Why mandatory vaccination for healthcare workers should not be scrapped.
     BMJ. 2022;376:o206.
     

     >> Share

     
     
257. IACOBUCCI G
     Covid-19: How prepared is England's NHS for mandatory vaccination?
     BMJ. 2022;376:o192.
     

     >> Share

     
     
258. 
     Covid-19 vaccines and treatments: we must have raw data, now.
     BMJ. 2022;376:o189.
     

     >> Share

     
     
259. DOSHI P, Godlee F, Abbasi K
     Covid-19 vaccines and treatments: we must have raw data, now.
     BMJ. 2022;376:o102.
     

     >> Share

     
     
260. WATERS A
     Covid-19: Reassess effects of mandatory vaccination on staffing, urge unions.
     BMJ. 2022;376:o139.
     

     >> Share

     
     
261. IACOBUCCI G
     Covid-19: Focus should be on new vaccines rather than boosters, says WHO.
     BMJ. 2022;376:o108.
     

     >> Share

     
     
262. DYER O
     Covid-19: Quebec to tax the unvaccinated as vaccine mandates spread in Europe.
     BMJ. 2022;376:o112.
     

     >> Share

     
     
263. GOH S
     Valneva could appeal to the vaccine hesitant and may be more effective for longer.
     BMJ. 2022;376:o48.
     

     >> Share

     
     
264. TANNE JH
     Covid-19: Vaccination during pregnancy is safe, finds large US study.
     BMJ. 2022;376:o27.
     

     >> Share

     
     
265. PULLA P
     How covid-19 vaccines exposed India's adverse events reporting system.
     BMJ. 2022;376:n3146.
     

     >> Share

     
     
266. IACOBUCCI G
     Covid-19: Fourth vaccine doses-who needs them and why?
     BMJ. 2022;376:o30.
     

     >> Share

     
     
267. CHEBLY KO
     Centring equity over exceptionalism in the global covid-19 response.
     BMJ. 2022;376:o20.
     

     >> Share

     
     
268. SHEPHERD A
     Vaccines wasted as Africa waits.
     BMJ. 2022;376:n3163.
     

     >> Share

     
     
269. 
     Covid-19: An urgent call for global "vaccines-plus" action.
     BMJ. 2022;376:o1.
     

     >> Share

     
     December 2021
270. 
     I am struggling to understand why patients decide not to get the covid vaccine.
     BMJ. 2021;375:n3152.
     

     >> Share

     
     
271. PRUGGER C, Spelsberg A, Keil U, Erviti J, et al
     Evaluating covid-19 vaccine efficacy and safety in the post-authorisation phase.
     BMJ. 2021;375:e067570.
     

     >> Share

     
     
272. PAGEL C, Squires A
     Schools: still a gaping hole in the English covid strategy.
     BMJ. 2021;375:n3149.
     

     >> Share

     
     
273. RICHTERMAN A, Scott J, Cevik M
     Covid-19 vaccines, immunity, and boosters.
     BMJ. 2021;375:n3105.
     

     >> Share

     
     
274. HAQUE Z
     Vaccine inequality may undermine the booster programme.
     BMJ. 2021;375:n3118.
     

     >> Share

     
     
275. GELLAD WF
     Myocarditis after vaccination against covid-19.
     BMJ. 2021;375:n3090.
     

     >> Share

     
     
276. HUSBY A, Hansen JV, Fosbol E, Thiesson EM, et al
     SARS-CoV-2 vaccination and myocarditis or myopericarditis: population based cohort study.
     BMJ. 2021;375:e068665.
     

     >> Share

     
     
277. HOPSON C
     If the NHS falls short on boosters, it won't be for want of trying.
     BMJ. 2021;375:n3106.
     

     >> Share

     
     
278. OSAMA T, Hodes S, Razai MS, Majeed A, et al
     Boosting the nation against covid-19: are the vaccination targets feasible?
     BMJ. 2021;375:n3094.
     

     >> Share

     
     
279. BRUXVOORT KJ, Sy LS, Qian L, Ackerson BK, et al
     Effectiveness of mRNA-1273 against delta, mu, and other emerging variants of SARS-CoV-2: test negative case-control study.
     BMJ. 2021;375:e068848.
     

     >> Share

     
     
280. IACOBUCCI G
     Covid-19: GPs are told to postpone routine care to focus on vaccine boosters in response to omicron.
     BMJ. 2021;375:n3083.
     

     >> Share

     
     
281. SARELA A
     Condemning consensus is not helpful.
     BMJ. 2021;375:n3073.
     

     >> Share

     
     
282. HASSAN F, London L, Gonsalves G
     Unequal global vaccine coverage is at the heart of the current covid-19 crisis.
     BMJ. 2021;375:n3074.
     

     >> Share

     
     
283. KMIETOWICZ Z
     Covid-19: Monoclonal antibodies authorised in US as alternative to vaccines for certain groups.
     BMJ. 2021;375:n3064.
     

     >> Share

     
     
284. SAUL H, Gursul D
     Stressing the personal benefits of the covid-19 vaccine might encourage more people to accept it.
     BMJ. 2021;375:n2923.
     

     >> Share

     
     
285. MAHASE E
     Covid-19: Do vaccines work against omicron-and other questions answered.
     BMJ. 2021;375:n3062.
     

     >> Share

     
     
286. WATERS SJ
     Mandatory covid-19 vaccination for healthcare workers: all employers are bound by health and safety laws to reduce risk.
     BMJ. 2021;375:n3039.
     

     >> Share

     
     
287. PIZZO M
     Mandatory vaccination for healthcare workers: consequences of denying bodily autonomy.
     BMJ. 2021;375:n3041.
     

     >> Share

     
     
288. TINARI S, Riva C
     Covid-19: Whatever happened to the Novavax vaccine?
     BMJ. 2021;375:n2965.
     

     >> Share

     
     
289. MCCARTNEY M
     Bureaucracy has created a mess for Novavax volunteers like me.
     BMJ. 2021;375:n2995.
     

     >> Share

     
     
290. MAHASE E
     Covid-19: "Mix and match" primary vaccines are safe and effective, study finds.
     BMJ. 2021;375:n3030.
     

     >> Share

     
     
291. PORTER S
     Mandatory covid-19 vaccination for healthcare workers: vaccinated and unvaccinated people seem as likely to infect others.
     BMJ. 2021;375:n3027.
     

     >> Share

     
     
292. WISE J
     Covid-19: Build on success of vaccination programme in reaching ethnic minority groups, report recommends.
     BMJ. 2021;375:n3003.
     

     >> Share

     
     
293. MAHASE E
     Covid-19: Antibody boost after third dose varies greatly by vaccine, study finds.
     BMJ. 2021;375:n3011.
     

     >> Share

     
     
294. AHMAD A, Haqmal M
     Strengthening routine polio vaccination in Afghanistan.
     BMJ. 2021;375:n2935.
     

     >> Share

     
     
295. ZHANG Y, Quigley A, Wang Q, MacIntyre CR, et al
     Non-pharmaceutical interventions during the roll out of covid-19 vaccines.
     BMJ. 2021;375:n2314.
     

     >> Share

     
     
296. AN Z, Wang F, Pan A, Yin Z, et al
     Vaccination strategy and challenges for consolidating successful containment of covid-19 with population immunity in China.
     BMJ. 2021;375:e066125.
     

     >> Share

     
     
297. TU H, Hu K, Zhang M, Zhuang Y, et al
     Effectiveness of 14 day quarantine strategy: Chinese experience of prevention and control.
     BMJ. 2021;375:e066121.
     

     >> Share

     
     November 2021
298. TORJESEN I
     Covid-19: Omicron may be more transmissible than other variants and partly resistant to existing vaccines, scientists fear.
     BMJ. 2021;375:n2943.
     

     >> Share

     
     
299. RAMCHANDANI R, Kazatchkine M, Liu J, Sudan P, et al
     Vaccines, therapeutics, and diagnostics for covid-19: redesigning systems to improve pandemic response.
     BMJ. 2021;375:e067488.
     

     >> Share

     
     
300. JUNG AS, Haldane V, Neill R, Wu S, et al
     National responses to covid-19: drivers, complexities, and uncertainties in the first year of the pandemic.
     BMJ. 2021;375:e068954.
     

     >> Share

     
     
301. CLARK H, Sirleaf EJ
     Ending this pandemic and securing the future.
     BMJ. 2021;375:n2914.
     

     >> Share

     
     
302. MAHASE E
     Covid-19: Vaccine uptake during pregnancy has increased but deprived areas lag behind, data show.
     BMJ. 2021;375:n2932.
     

     >> Share

     
     
303. ARONSON JK
     When I use a word . . . . No jab, no job? A benefit:harm balance analysis.
     BMJ. 2021;375:n2934.
     

     >> Share

     
     
304. YAMEY G, McDade KK, Brennan RJ, Abubakar A, et al
     Preventing pandemics in the world's most vulnerable settings.
     BMJ. 2021;375:n2897.
     

     >> Share

     
     
305. ISRAEL A, Merzon E, Schaffer AA, Shenhar Y, et al
     Elapsed time since BNT162b2 vaccine and risk of SARS-CoV-2 infection: test negative design study.
     BMJ. 2021;375:e067873.
     

     >> Share

     
     
306. EXTANCE A
     mRNA vaccines: hope beneath the hype.
     BMJ. 2021;375:n2744.
     

     >> Share

     
     
307. MAHASE E
     Covid-19: What next for the Valneva vaccine?
     BMJ. 2021;375:n2839.
     

     >> Share

     
     
308. IACOBUCCI G
     Covid-19 and pregnancy: vaccine hesitancy and how to overcome it.
     BMJ. 2021;375:n2862.
     

     >> Share

     
     
309. ALTMANN D, Boyton R
     Covid-19 caseload in the UK-assessments and mitigations.
     BMJ. 2021;375:n2843.
     

     >> Share

     
     
310. PUNTIS J
     Test and trace system continues to fail.
     BMJ. 2021;375:n2808.
     

     >> Share

     
     
311. IACOBUCCI G
     Covid-19: England is preparing to offer annual booster vaccination, says NHS boss.
     BMJ. 2021;375:n2824.
     

     >> Share

     
     
312. SRIVASTAVA K
     Fake covid vaccines boost the black market for counterfeit medicines.
     BMJ. 2021;375:n2754.
     

     >> Share

     
     
313. MAHASE E
     Covid-19: Booster vaccine gives "significant increased protection" in over 50s.
     BMJ. 2021;375:n2814.
     

     >> Share

     
     
314. TALIC S, Shah S, Wild H, Gasevic D, et al
     Effectiveness of public health measures in reducing the incidence of covid-19, SARS-CoV-2 transmission, and covid-19 mortality: systematic review and meta-analysis.
     BMJ. 2021;375:e068302.
     

     >> Share

     
     
315. DYER O
     Covid-19: US doctor who called masks "dangerous" and vaccines a "human experiment" dies of coronavirus.
     BMJ. 2021;375:n2796.
     

     >> Share

     
     
316. PATTERSON L
     Encouraging covid vaccine uptake and safe behaviours-an uphill struggle against government complacency.
     BMJ. 2021;375:n2773.
     

     >> Share

     
     
317. DYER O
     Covid-19: Moderna seeks to exclude US government scientists from vaccine patents, despite public investment.
     BMJ. 2021;375:n2781.
     

     >> Share

     
     
318. LOOI MK
     The world according to covid vaccine coverage.
     BMJ. 2021;375:n2732.
     

     >> Share

     
     
319. RIMMER A
     Covid vaccination to be mandatory for NHS staff in England from spring 2022.
     BMJ. 2021;375:n2733.
     

     >> Share

     
     
320. WISE J
     Covid-19: Pfizer vaccine provides 90% protection against infection in children aged 5-11, study finds.
     BMJ. 2021;375:n2746.
     

     >> Share

     
     
321. IACOBUCCI G
     Covid-19: How is the UK's vaccine booster programme faring?
     BMJ. 2021;375:n2702.
     

     >> Share

     
     
322. TORJESEN I
     HPV vaccine cut cervical cancer rates in England by 87.
     BMJ. 2021;375:n2689.
     

     >> Share

     
     
323. TANNE JH
     Covid-19: Biden administration sets 4 January deadline to vaccinate most US workers.
     BMJ. 2021;375:n2708.
     

     >> Share

     
     
324. TANNE JH
     Covid-19: US doctors begin administering vaccine to children aged 5-11.
     BMJ. 2021;375:n2693.
     

     >> Share

     
     
325. SLEAT D, Innes K, Parker I
     Are vaccine passports and covid passes a valid alternative to lockdown?
     BMJ. 2021;375:n2571.
     

     >> Share

     
     
326. SHEPHERD A
     Taliban lifts ban on polio vaccinations in Afghanistan.
     BMJ. 2021;375:n2656.
     

     >> Share

     
     
327. THACKER PD
     Covid-19: Researcher blows the whistle on data integrity issues in Pfizer's vaccine trial.
     BMJ. 2021;375:n2635.
     

     >> Share

     
     
328. SOKOL D
     Covid-19 vaccination should be mandatory for healthcare workers.
     BMJ. 2021;375:n2670.
     

     >> Share

     
     
329. ENGLISH PMB
     Covid vaccine committee decisions: don't forget JCVI has little or no extra resources to do many times its usual work.
     BMJ. 2021;375:n2646.
     

     >> Share

     
     October 2021
330. TORJESEN I
     Covid-19: One in four vaccinated people living in households with a covid-19 case become infected, study finds.
     BMJ. 2021;375:n2638.
     

     >> Share

     
     
331. FEINMANN J
     Covid-19: global vaccine production is a mess and shortages are down to more than just hoarding.
     BMJ. 2021;375:n2375.
     

     >> Share

     
     
332. DYER O
     Covid-19: US and China prepare for mass vaccination of children under 12.
     BMJ. 2021;375:n2631.
     

     >> Share

     
     
333. MAHASE E
     Covid-19: Just a third of blood cancer patients had antibodies against delta variant after two vaccine doses, study finds.
     BMJ. 2021;375:n2623.
     

     >> Share

     
     
334. TAYLOR L
     Covid-19: Protect healthcare workers with vaccines, urges WHO after 115 000 die worldwide.
     BMJ. 2021;375:n2592.
     

     >> Share

     
     
335. CHRISTIE B
     Covid-19: Vaccines are highly effective in preventing deaths from delta variant, study indicates.
     BMJ. 2021;375:n2582.
     

     >> Share

     
     
336. IACOBUCCI G
     The UK government's covid complacency shows lessons haven't been learned.
     BMJ. 2021;375:n2584.
     

     >> Share

     
     
337. MAHASE E
     Covid-19: Valneva's vaccine produces stronger immune response than AstraZeneca's, company reports.
     BMJ. 2021;375:n2551.
     

     >> Share

     
     
338. ABBAS-HANIF A, Modi N, Smith SK, Majeed A, et al
     Covid-19 treatments and vaccines must be evaluated in pregnancy.
     BMJ. 2021;375:n2377.
     

     >> Share

     
     
339. PATERLINI M
     Covid-19: Sweden, Norway, and Finland suspend use of Moderna vaccine in young people "as a precaution".
     BMJ. 2021;375:n2477.
     

     >> Share

     
     
340. MAHASE E
     Covid-19: Trial participants are offered approved vaccines so they can travel abroad.
     BMJ. 2021;375:n2474.
     

     >> Share

     
     
341. WISE J
     WHO hails "historic day" as it recommends malaria vaccine.
     BMJ. 2021;375:n2455.
     

     >> Share

     
     
342. MAHASE E
     Covid-19: Vaccine advisory committee must be more transparent about decisions, say researchers.
     BMJ. 2021;375:n2452.
     

     >> Share

     
     
343. BOYTCHEV H
     Covid-19: Why the Balkans' vaccine rollout lags behind most of Europe.
     BMJ. 2021;375:n2412.
     

     >> Share

     
     
344. WISE J
     Vaccinating against covid and flu at same time is safe, study shows.
     BMJ. 2021;375:n2411.
     

     >> Share

     
     
345. PAVORD S, Hunt BJ, Horner D, Bewley S, et al
     Vaccine induced immune thrombocytopenia and thrombosis: summary of NICE guidance.
     BMJ. 2021;375:n2195.
     

     >> Share

     
     
346. DOSHI P
     Covid-19: Spreading vaccine "misinformation" puts licence at risk, US boards tell physicians.
     BMJ. 2021;375:n2417.
     

     >> Share

     
     September 2021
347. MAJEED A, Hodes S, Marks S
     Consent for covid-19 vaccination in children.
     BMJ. 2021;374:n2356.
     

     >> Share

     
     
348. MAHASE E
     Covid-19: Fully vaccinated patients no longer need to test or isolate before elective procedures, hospitals are told.
     BMJ. 2021;374:n2383.
     

     >> Share

     
     
349. DYER O
     Covid-19: New York's health workers agree to vaccinate as mandate bites.
     BMJ. 2021;374:n2390.
     

     >> Share

     
     
350. MENDIS S
     Regional vaccine production is key to ensuring equity.
     BMJ. 2021;374:n2354.
     

     >> Share

     
     June 2021
351. LI X, Ostropolets A, Makadia R, Shoaibi A, et al
     Characterising the background incidence rates of adverse events of special interest for covid-19 vaccines in eight countries: multinational network cohort study.
     BMJ. 2021;373:n1435.
     

     >> Share

     
     

Free Medical Abstracts
Privacy Policy
Sponsors
Share